Exact Mass: 829.700646
Exact Mass Matches: 829.700646
Found 500 metabolites which its exact mass value is equals to given mass value 829.700646,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PC(15:0/24:1(15Z))
PC(15:0/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/24:1(15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(22:0/P-18:0)
C48H96NO7P (829.6924035999998)
PC(22:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-18:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(22:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(22:0/P-18:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(24:0/P-16:0)
C48H96NO7P (829.6924035999998)
PC(24:0/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/P-16:0), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.
PC(24:1(15Z)/15:0)
PC(24:1(15Z)/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:1(15Z)/15:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.
PE(18:0/24:1(15Z))
PE(18:0/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/24:1(15Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(18:1(11Z)/24:0)
PE(18:1(11Z)/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(11Z)/24:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(18:1(9Z)/24:0)
PE(18:1(9Z)/24:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:1(9Z)/24:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(20:0/22:1(13Z))
PE(20:0/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/22:1(13Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of erucic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(20:1(11Z)/22:0)
PE(20:1(11Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/22:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:1(11Z)/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/22:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PE(22:0/20:1(11Z))
PE(22:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/20:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(22:1(13Z)/20:0)
PE(22:1(13Z)/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:1(13Z)/20:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The erucic acid moiety is derived from seed oils and avocados, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(24:0/18:1(11Z))
PE(24:0/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/18:1(11Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(24:0/18:1(9Z))
PE(24:0/18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:0/18:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of oleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PE(24:1(15Z)/18:0)
PE(24:1(15Z)/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(24:1(15Z)/18:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of stearic acid at the C-2 position. The nervonic acid moiety is derived from fish oils, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.
PC(P-16:0/24:0)
C48H96NO7P (829.6924035999998)
PC(P-16:0/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/24:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of lignoceric acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/24:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of lignoceric acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(P-18:0/22:0)
C48H96NO7P (829.6924035999998)
PC(P-18:0/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/22:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of behenic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.
PC(O-18:1(9Z)/22:0)
C48H96NO7P (829.6924035999998)
PC(O-18:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(9Z)/22:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-18:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-18:1(9Z)/22:0), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of behenic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PE-NMe2(16:0/24:1(15Z))
PE-NMe2(16:0/24:1(15Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(16:1(9Z)/24:0)
PE-NMe2(16:1(9Z)/24:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(16:1(9Z)/24:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(18:0/22:1(13Z))
PE-NMe2(18:0/22:1(13Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of erucic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(18:1(11Z)/22:0)
PE-NMe2(18:1(11Z)/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(11Z)/22:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
PE-NMe2(18:1(9Z)/22:0)
PE-NMe2(18:1(9Z)/22:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(9Z)/22:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.
1-O-(beta-D-glucopyranosyl)-(2S,3S,4R)-2-((2R,15Z)-2-hydroxy-15-tetracosenoylamino)-14-methylhexadecane-1,3,4-triol
(8E)-N-2-hydroxytricosanoyl-1-O-beta-D-glucopyranosyl-4-hydroxy-8-sphingenine
1-O-(beta-D-glucopyranosyl)-(2S,3S,4R,12Z)-2-{[(2R)-2-hydroxytetracosanoyl]amino}octadec-12-ene-1,3,4-triol|mucusoside
1-O-beta-D-glucopyranosyl-(2S,3S,4R,10E)-2-[(2R)-2-hydroxytricosanoyl-amino]-10-octadecene-1,3,4-triol
Lecithin
C48H96NO7P (829.6924035999998)
PC(O-18:0/22:1(11Z))
C48H96NO7P (829.6924035999998)
PC(O-20:0/20:1(11Z))
C48H96NO7P (829.6924035999998)
PC(P-20:0/20:0)
C48H96NO7P (829.6924035999998)
PC O-40:1
C48H96NO7P (829.6924035999998)
1-octadecyl-2-[(11Z)-docosenoyl]-sn-glycero-3-phosphocholine
C48H96NO7P (829.6924035999998)
A phosphatidylcholine O-40:1 in which the alkyl and acyl groups at positions 1 and 2 are octadecyl and (11Z)-docosenoyl respectively.
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentacosanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(Z)-tetracos-15-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tricosanoylamino)icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-[[(Z)-3-hydroxytetracos-15-enoyl]amino]octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C47H94N2O7P+ (829.6798283999999)
1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine
A glycophytoceramide having an alpha-D-galactopyranosyl residue at the O-1 position and a tetracosanoyl group attached to the nitrogen.
1-O-(alpha-D-glucopyranosyl)-N-tetracosanylphytosphingosine
A glycophytoceramide having an alpha-D-glucopyranosyl residue at the O-1 position and an tetracosanoyl group attached to the nitrogen.
N-pentacosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine
2-[hydroxy-[(2S,3R)-3-hydroxy-2-(pentacosanoylamino)octadec-5-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxy-15-methylhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxy-14-methylhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
[3-dodecoxy-2-[(Z)-octacos-17-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
(20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]octatriaconta-20,23,26,29,32,35-hexaenamide
(22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]tetraconta-22,25,28,31,34,37-hexaenamide
(24Z,27Z,30Z,33Z,36Z,39Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]dotetraconta-24,27,30,33,36,39-hexaenamide
(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]octatriaconta-14,17,20,23,26,29,32,35-octaenamide
(15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]hexatriaconta-15,18,21,24,27,30,33-heptaenamide
(16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]tetratriaconta-16,19,22,25,28,31-hexaenamide
(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(E)-1,3-dihydroxyhexacos-4-en-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide
(18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]dotetraconta-18,21,24,27,30,33,36,39-octaenamide
(18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]hexatriaconta-18,21,24,27,30,33-hexaenamide
(21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]dotetraconta-21,24,27,30,33,36,39-heptaenamide
(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E,12E)-1,3-dihydroxydotriaconta-4,8,12-trien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide
(10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctacosa-4,8,12-trien-2-yl]octacosa-10,13,16,19,22,25-hexaenamide
(8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxytriaconta-4,8,12-trien-2-yl]hexacosa-8,11,14,17,20,23-hexaenamide
(16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]tetraconta-16,19,22,25,28,31,34,37-octaenamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxyhexacosa-4,8-dien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide
(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxyoctadecan-2-yl)octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide
(20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]tetratetraconta-20,23,26,29,32,35,38,41-octaenamide
(14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxytetracosa-4,8,12-trien-2-yl]dotriaconta-14,17,20,23,26,29-hexaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-(1,3-dihydroxydocosan-2-yl)tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E)-1,3-dihydroxytriaconta-4,8-dien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide
(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxyicos-4-en-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide
(17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-(1,3-dihydroxydodecan-2-yl)tetratetraconta-17,20,23,26,29,32,35,38,41-nonaenamide
(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxyhexadecan-2-yl)tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide
(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E)-1,3-dihydroxyoctacosa-4,8-dien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E,12E)-1,3-dihydroxytetratriaconta-4,8,12-trien-2-yl]docosa-4,7,10,13,16,19-hexaenamide
(19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]tetraconta-19,22,25,28,31,34,37-heptaenamide
(15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-N-(1,3-dihydroxytetradecan-2-yl)dotetraconta-15,18,21,24,27,30,33,36,39-nonaenamide
(23Z,26Z,29Z,32Z,35Z,38Z,41Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetratetraconta-23,26,29,32,35,38,41-heptaenamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxyicosan-2-yl)hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide
(17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]octatriaconta-17,20,23,26,29,32,35-heptaenamide
(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxytetracosa-4,8-dien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide
(12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexacosa-4,8,12-trien-2-yl]triaconta-12,15,18,21,24,27-hexaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-(1,3-dihydroxytetracosan-2-yl)dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide
(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxydocos-4-en-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide
3-Hydroxy-2-(2-hydroxypentacosanoylamino)tetracosane-1-sulfonic acid
3-Hydroxy-2-(2-hydroxyhexacosanoylamino)tricosane-1-sulfonic acid
3-Hydroxy-2-(2-hydroxytetracosanoylamino)pentacosane-1-sulfonic acid
3-Hydroxy-2-(2-hydroxytricosanoylamino)hexacosane-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] nonadecanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] tetracosanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] hexacosanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] tricosanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octacosoxypropan-2-yl] (Z)-pentadec-9-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (Z)-docos-13-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (Z)-icos-11-enoate
C48H96NO7P (829.6924035999998)
(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (Z)-henicos-11-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentacosoxypropan-2-yl] (Z)-octadec-9-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (Z)-tetracos-13-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexacosoxypropan-2-yl] (Z)-heptadec-9-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] docosanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] henicosanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptacosoxypropan-2-yl] (Z)-hexadec-9-enoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] heptadecanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-octacos-17-enoate
C48H96NO7P (829.6924035999998)
2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxypentacosane-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] pentadecanoate
C48H96NO7P (829.6924035999998)
(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxypentacosa-4,8-diene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (Z)-hexacos-15-enoate
C48H96NO7P (829.6924035999998)
(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxypentacos-4-ene-1-sulfonic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] octacosanoate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetracosoxypropan-2-yl] (Z)-nonadec-9-enoate
C48H96NO7P (829.6924035999998)
[3-[(Z)-heptadec-9-enoxy]-2-tricosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-[(Z)-icos-11-enoyl]oxy-3-icosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-heptacosanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-heptacosoxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-[(Z)-docos-13-enoxy]-2-octadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-hexadecanoyloxy-3-[(Z)-tetracos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-[(Z)-hexadec-9-enoyl]oxy-3-tetracosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-[(Z)-henicos-11-enoxy]-2-nonadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-henicosoxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-[(Z)-hexacos-15-enoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-hexacosoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-[(Z)-henicos-11-enoyl]oxy-3-nonadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-docosoxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-pentacosoxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-pentacosanoyloxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-icosanoyloxy-3-[(Z)-icos-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-dodecanoyloxy-3-[(Z)-octacos-17-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-[(Z)-heptadec-9-enoyl]oxy-3-tricosoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-henicosanoyloxy-3-[(Z)-nonadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
4-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-henicosanoyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(Z)-henicos-11-enoyl]oxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-heptadecanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[3-hexadecoxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-[(Z)-hexacos-15-enoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] pentacosanoate
C48H96NO7P (829.6924035999998)
[2-hexacosanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[3-[(Z)-hexadec-9-enoxy]-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-[(Z)-docos-13-enoyl]oxy-3-octadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[2-docosanoyloxy-3-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] heptacosanoate
C48H96NO7P (829.6924035999998)
4-[2-hexadecanoyloxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxyheptadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-[(E)-henicos-9-enoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] tricosanoate
C48H96NO7P (829.6924035999998)
4-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-3-[(E)-hexadec-1-enoxy]-2-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
2-[[(E,2S,3R)-2-(docosanoylamino)-3-hydroxyhenicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-octadecanoyloxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-3-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-heptadecanoyloxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-2-tricosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-octadec-11-enoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-octadecanoyloxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(10E,12E)-octadeca-10,12-dienoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-heptadec-7-enoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] pentacosanoate
C48H96NO7P (829.6924035999998)
4-[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(2S,3R)-2-[[(E)-docos-13-enoyl]amino]-3-hydroxyhenicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[2-[(E)-docos-11-enoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-hexacos-11-enoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-docosanoyloxy-2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(10E,12E)-octadeca-10,12-dienoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-henicosanoyloxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[2-[(E)-henicos-9-enoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-hexadecanoyloxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)nonadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-[(E)-docos-11-enoyl]oxy-2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-henicosanoyloxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-heptadecanoyloxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-octadec-11-enoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(E,2S,3R)-2-(docosanoylamino)-3-hydroxyhenicos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
[(2R)-2-docosanoyloxy-3-[(E)-octadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
4-[2-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tricosanoylamino)icos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-nonadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-heptadec-7-enoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(E)-nonadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentacosanoylamino)octadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-hexacos-11-enoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(E)-hexadec-7-enoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-docosanoyloxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxydocos-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-icosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-pentacosanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(7E,9E)-nonadeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
[(2R)-2-icosanoyloxy-3-[(E)-icos-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C48H96NO7P (829.6924035999998)
4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
4-[3-[(E)-hexadec-7-enoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate
2-[hydroxy-[(E)-3-hydroxy-2-(tricosanoylamino)icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(tetracosanoylamino)nonadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxyheptacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(docosanoylamino)-3-hydroxyhenicos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(tridecanoylamino)triacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(octadecanoylamino)pentacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(octacosanoylamino)pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-docos-11-enoyl]amino]-3-hydroxyhenicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]octacosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(tetradecanoylamino)nonacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(pentacosanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-nonacos-14-enoyl]amino]tetradecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]tricosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]triacontoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-pentacos-11-enoyl]amino]octadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]icosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]pentacosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]nonacosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(nonadecanoylamino)tetracos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]tetracosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(pentadecanoylamino)octacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(hexadecanoylamino)-3-hydroxyheptacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(heptadecanoylamino)-3-hydroxyhexacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(henicosanoylamino)-3-hydroxydocos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(nonacosanoylamino)tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-octacos-13-enoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-hexacos-11-enoyl]amino]-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(icosanoylamino)tricos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxydocosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(heptacosanoylamino)-3-hydroxyhexadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-heptacos-12-enoyl]amino]-3-hydroxyhexadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(hexacosanoylamino)-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(triacontanoylamino)tridec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyheptacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyhexacosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxyheptadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(decanoylamino)-3-hydroxytritriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetratriacont-23-enoyl]amino]nonoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)dotriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(8E,12E)-3,4-dihydroxy-2-(tetracosanoylamino)octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C47H94N2O7P+ (829.6798283999999)
2-[[(E)-3,4-dihydroxy-2-[[(Z)-tetracos-13-enoyl]amino]octadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C47H94N2O7P+ (829.6798283999999)
2-[[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxyhenicosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-triacont-19-enoyl]amino]tridecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[3,4-dihydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]octadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C47H94N2O7P+ (829.6798283999999)
2-[[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxydocosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(pentatriacontanoylamino)oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)pentatriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(dodecanoylamino)-3-hydroxyhentriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(heptanoylamino)-3-hydroxyhexatriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(dotriacontanoylamino)-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]triacontoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(tetratriacontanoylamino)non-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[2-[[(Z)-dotriacont-21-enoyl]amino]-3-hydroxyundecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-octacos-17-enoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]nonadecoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(hexanoylamino)-3-hydroxyheptatriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(tritriacontanoylamino)dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]pentacosoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[[(E)-2-(hentriacontanoylamino)-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)tetratriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C48H98N2O6P+ (829.7162118000001)
phosphatidylcholine O-40:1
C48H96NO7P (829.6924035999998)
An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 40 carbons and 1 double bond.
Hex1Cer(42:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(39:1)
C48H96NO7P (829.6924035999998)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(41:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved